Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ: MRNA )

42.39 +3.89 (+10.10%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,684,341
Open 38.40
Bid (Size) 43.11 (4)
Ask (Size) 43.17 (40)
Prev. Close 38.50
Today's Range 36.99 - 42.54
52wk Range 31.94 - 170.47
Shares Outstanding 385,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Moderna Shares Are Up Today: What's Going On?
Moderna shares closed up Thursday gaining momentum following recent comments by Oracle Chairman Larry Ellison about the role of artificial intelligence in revolutionizing cancer treatment. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
Ellison, Oracle's chairman, pointed to the use of AI to develop drugs like Moderna's cancer vaccine. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+0.93%
+0.93%
1 Month
+5.26%
+5.26%
3 Month
-19.72%
-19.72%
6 Month
-64.79%
-64.79%
1 Year
-58.08%
-58.08%

More News

Read More
These 3 Stocks Are Down to Start 2025. What's Going On?
Via The Motley Fool
Moderna Unusual Options Activity For January 22
Via Benzinga
Seagate Posts Upbeat Earnings, Joins Netflix, Travelers, Teledyne Technologies And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why Is Moderna Stock Trading Higher On Tuesday?
Via Benzinga
Where Will Moderna Be in 3 Years?
Via The Motley Fool
After a Reset Year, Is Moderna Stock Poised for a Comeback?
Via MarketBeat
Exposures COVID-19 Product Safety
Bird Flu Update: First Commercial Case In Georgia, Moderna Receives $590 Million To Develop Vaccine
Via Benzinga
Moderna Stock Jumps On $590M US Award For Bird Flu Vaccine Development, But Retail Doubts Longevity Under Trump
Via Stocktwits
Charles Schwab Posts Upbeat Earnings, Joins Redwire, Evolus, Replimune Group And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Is Moderna Stock a Buy?
Via The Motley Fool
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now?
Via The Motley Fool
3M, Netflix And 3 Stocks To Watch Heading Into Tuesday
Via Benzinga
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
These Were the 5 Worst-Performing Stocks in the S&P 500 in 2024
Via The Motley Fool
Topics Stocks
Exposures US Equities
Moderna Announces Updates on Pandemic Influenza Program
Via ACCESS Newswire
Is Moderna a Bad-News Buy for 2025?
Via The Motley Fool
Down 79%, Is Moderna Stock a Bad-News Buy on the Dip?
Via The Motley Fool
Moderna Stock: A Deep Dive Into Analyst Perspectives (10 Ratings)
Via Benzinga
Is Moderna Stock a No-Brainer Buy on the Sell-Off?
Via The Motley Fool
Stock Market Rises On Tame Inflation, Bank Earnings: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Via Investor's Business Daily
Topics Government
Exposures Political
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing
Via Benzinga
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?
Via Investor's Business Daily
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.